Article Text

Download PDFPDF

56 Micromanaging lupus nephritis: mir17–92 modulates regulatory t cell activity by targeting foxp3 co-regulators
  1. HY Yang1,
  2. CY Wu2 and
  3. JL Huang2
  1. 1Chang-Gung Memorial Hospital- Linko Branch, Nephrology, Taoyuan, Taiwan R.O.C
  2. 2Chang-Gung Memorial Hospital- Linko Branch, Paediatrics, Taoyuan, Taiwan R.O.C


Background and aims Regulatory T (Treg) cells play a critical role in maintaining self-tolerance and controlling the magnitude of physiologic immune response. The Treg transcription factor forkhead box P3 (Foxp3) works in concert with other co-regulator molecules including Eos to determine suppressive phenotype of Treg. We identified miR17-92 cluster targeting Eos through bioinformatics approaches.

Methods We generated T-cell-specific miR-17–92 null (mir17-92 -/-) mice by mating mir17-92flox/flox mutants to CD4-Cre+ transgenic mice. Treg from mir17-92 -/- mice will be isolated, followed by suppression assay to evaluate the role of the miR-17–92 cluster in Treg function. We applied pristane to induce lupus nephropathy in wild type and mir17-92 -/- mice. We examined the up-stream promoter region of miR-17–92 for binding sites of down-stream mediators of IL-6 signalling, verified by chromatin immunoprecipitation assay.

Results The inflammatory cytokine IL-6 unregulated miR17-92 through HIF-1. MiR17-92 cluster.actively suppressed Eos expression. Knockdown of miR17-92 in Treg enhanced their suppressive activity. Mir17-92 T cell specific deficiency mitigated pristane induced-lupus nephropathy associated with diminished Th17 cells and autoantibody. Moreover, histological analysis revealed a lower mean renal histopathology score and less compliment deposition. Ectopic expression of miR-17 downmodulated the suppression functions of Tregs and provided Treg with partial effector activity via the derepression of cytokine genes.

Conclusions Our studies suggest that miR17-92 modulates Treg cell function by targeting Eos and potentially additional Foxp3 co-regulators, unveiling the future therapeutic potential of microRNA manipulation in lupus nephritis.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.